jointly hosted by FICAN West and Neurocenter Finland Turku region

Date: 16.3.2021

Time: 12.00 -15.30

This webinar is open for all and free to participants. Registration(by March 12th 2021) via link below. The webinar will take place in Zoom application and the participation link will be send by email before the event. The event will be held in English.

Schedule

12.00 –12.15 Welcome words from the organisers – Adjunct Professor, MD, Ville Vuorinen, Neurocenter, Turku University Hospital

12.15 –12.35 Phosphatase targeting of brain cancers – Professor Jukka Westermarck, Turku Bioscience Centre and Biomedical Institute, University of Turku

12.35 -12.45 Discussion

12.45 –13.05 Vulnerabilities in glioblastoma stem cells – Professor Pirjo Laakkonen, Translational Cancer Medicine Research Program, Faculty of Medicine and Laboratory Animal Centre, HiLIFE -Helsinki Insitute of Life Science, University Helsinki

13.05 -13.15 Discussion

13.15 –13.35 Targeting the DNA damage response in clinically- and surgically-relevant patient-derived models of glioblastoma – Ola Rominiyi(Research Fellow), Department of Oncology & Metabolism, University of Sheffield Medical School, UK

13.35 -13.45 Discussion

13.45 -14.00 BREAK

14.00 -14.20 Clinical, molecular genetic and translational applications of brain tumours – Adjunct Professor, MD, Joonas Haapasalo, Unit of Neurosurgery, Tampere University Hospital

14.20 -14.30 Discussion

14.30 –14.50 Oncologic treatment of malignant glioma -where do we stand now? – Professor, MD, Heikki Minn, Department of Oncology and Radiotherapy, Turku University Hospital

14.50 -15.00 Discussion

15.00 –15.20 Research opportunities offered by Auria Biobank – Data-analyst, Niina Pitkänen, Auria Biobank

15.20 -15.30 Discussion and final words from the organisers – Professor, MD, Panu Jaakkola, Department of Oncology and Radiotherapy, Turku University Hospital, Western Finland Cancer Centre (FICAN West)

For more information:

Sari Karppinen, Account Manager, sari.karppinen@uef.fi